Log in
Log in
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     


Delayed Nyse  -  04:00:02 2023-03-24 pm EDT
8.820 USD   +0.34%
03/14Transcript : Elanco Animal Health Incorporated Presents at Barclays Global Healthcare Conference, Mar-14-2023 08:30 AM
03/14Tyson Ventures invests in Athian's cloud-based carbon credit marketplace for livestock sector
03/13Insider Buy: Elanco Animal Health
Business Summary
Logo Elanco Animal Health Incorporated
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its Farm Animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others.

Number of employees : 9 740 people.
Sales per Business
Pet Health2 138.0048.5%
Farm Animal - Cattle944.0021.4%
Farm Animal - Poultry716.0016.2%
Farm Animal - Swine384.008.7%
Farm Animal - Aqua175.004%
Contact Manufacturing54.001.2%
USD in Million
Sales per region
International2 641.0055.4%2 446.0055.5% -7.38%
United States2 124.0044.6%1 965.0044.5% -7.49%
USD in Million
Name Title Age Since
Jeffrey Simmons President, Chief Executive Officer & Director 54 2018
Todd Young Chief Financial Officer & Executive Vice President 50 -
Christopher Keeley Chief Information Officer & Senior Vice President - -
David Kinard EVP-Human Resources & Corporate Communications 55 -
Kathryn Grissom Head-Investor Contact - -
Marcela A. Kirberger Secretary, Executive VP & General Counsel 55 2021
Roy Riggs Director-Dairy Business Unit - -
Ramiro M. Cabral Executive VP & President-Elanco International 50 -
David Urbanek Executive Vice President-Manufacturing & Quality 55 2018
Sara Place, Dr. Chief Sustainability Officer - 2019
Members of the board
Name Title Age Since
R. Hoover Independent Chairman 76 2018
Kapila Kapur Anand Independent Director 68 2018
Michael J. Harrington Independent Director 59 2018
Lawrence Kurzius Independent Director 64 2018
John Bilbrey Independent Director 65 2019
Deborah Turner Kochevar, Dr. Independent Director 65 2019
Kirk P. McDonald Independent Director 55 2019
Denise Vera Scots-Knight, Dr. Independent Director 63 2019
Art A. Garcia Independent Director 60 2019
Paul Herendeen Independent Director 66 2020
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 491,543,501 472,908,168 96.2% 0 0.0% 96.2%
Dodge & Cox 84,775,075 17.3%
The Vanguard Group, Inc. 44,699,964 9.10%
PRIMECAP Management Co. 32,983,562 6.71%
Amundi Asset Management US, Inc. 18,737,149 3.81%
T. Rowe Price Associates, Inc. (Investment Management) 18,651,639 3.80%
Franklin Mutual Advisers LLC 18,570,782 3.78%
Ontario Teachers' Pension Plan Board 17,922,193 3.65%
Shapiro Capital Management LLC 13,522,352 2.75%
Janus Henderson Investors US LLC 11,392,972 2.32%
BlackRock Fund Advisors 10,572,114 2.15%
Company contact information
Elanco Animal Health, Inc.
2500 Innovation Way
Greenfield, IN 46140

Phone : +1.877.352.6261
Web : http://www.elanco.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Elanco Animal Health Incorporated
MarketScreener: Created by Investors for Investors!
100% Free Registration